Saturday 17 October 2026 Export REGN’s income statement to Excel — free account

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, up 0.99% from fiscal 2024. In the quarter to June 2026, revenue grew 16.7%, EPS fell 4.68%, free cash flow fell 29.3% and total debt fell 26.6%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for three consecutive years.

790.74 5.60 −0.70%

Follow REGN

Alert me

Market cap: $82.0B
P/E: 18.9×
Fwd P/E: 16.5×
Dividend yield: 0.47%
F-score: 5/9
Altman Z: 7.49
Beneish M: −2.53
Dividend safety: 77/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	12.94	17.90	18.17	14.88
P/S ratio Full definition →		4.09	5.63	5.39	4.13
P/FCF ratio Full definition →		15.01	21.44	21.20	17.93
P/Operating CF Full definition →		35.99	68.97	74.48	78.84
P/B ratio Full definition →		1.88	2.58	2.56	2.02
Price to Tangible BV Full definition →		1.97	2.69	2.67	2.11
EV/Sales Full definition →		3.79	5.32	5.03	3.84
EV/EBITDA Full definition →		12.82	18.52	18.01	13.63
EV/Operating CF Full definition →		10.65	15.33	14.98	12.73
EV/FCF Full definition →		13.92	20.27	19.81	16.67
Quick Ratio Full definition →		3.19	3.28	2.84	2.63
Current Ratio Full definition →		4.06	4.13	3.57	3.34
Net Debt/EBITDA Full definition →		(4.93)	(5.76)	(8.83)	(4.24)
Debt/Assets Full definition →		6.74%	6.67%	4.86%	4.76%
Debt/Equity Full definition →		0.09	0.09	0.06	0.06
Asset Turnover Full definition →		0.37	0.37	0.38	0.39
Operating CF/Net income Full definition →		1.11	1.39	1.48	0.63
Capex/Depreciation Full definition →		(1.79)	(2.00)	(2.27)	(2.35)
Interest Coverage Full definition →		53.20	72.12	49.84	117.59
Research and Development Expense of Revenue Full definition →		39.29%	41.86%	42.81%	38.03%
Selling, General and Administrative Expense of Revenue Full definition →		17.52%	19.95%	17.96%	15.43%
Intangible Assets out of Total Assets Full definition →		0.03	0.03	0.03	0.03
Share Based Compensation of Revenue Full definition →		6.31%	6.42%	7.14%	5.66%
Graham Net Nets Full definition →		0.15	0.11	0.11	0.13
Graham Number Full definition →		540.43	538.44	537.71	539.34
Earnings Yield Full definition →		7.73%	5.59%	5.50%	6.72%
Free Cash Flow Yield Full definition →		6.66%	4.66%	4.72%	5.58%
Revenue per Share Full definition →		36.24	37.13	34.67	41.74
Operating CF per Share Full definition →		15.62	11.19	10.37	7.91
Capex per Share Full definition →		(2.36)	(2.78)	(2.69)	(2.83)
Free Cash Flow per Share Full definition →		13.26	8.41	7.69	5.08
Cash per Share Full definition →		81.50	82.27	84.17	77.77
Shareholders Equity per Share Full definition →		298.82	298.82	302.15	308.48
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		298.82	298.82	302.15	308.48
Free Cash Flow Full definition →		1,374.00	880.00	799.40	521.80
Working Capital Full definition →		13,555.60	13,653.50	13,101.50	12,915.40
Capital Expenditures Full definition →		(244.70)	(290.70)	(279.50)	(291.20)
Net Current Asset Value Full definition →		8,769.10	8,720.10	8,764.00	8,426.80
EV/EBIT Full definition →		14.64	21.34	20.69	15.51
Capex to Sales Full definition →		0.07	0.07	0.08	0.07
Price to Operating Income Full definition →		15.79	22.57	22.14	16.68
Other line items
Average Receivables Full definition →		5,897.10	5,976.50	5,646.00	6,087.70
Average Payables Full definition →		700.55	864.25	866.30	941.60
Average Inventory Full definition →		3,136.20	3,144.05	3,148.00	3,144.95
Average Assets Full definition →		38,805.65	39,159.05	39,207.00	39,974.90
Average Common Equity Full definition →		30,141.85	30,305.25	30,405.60	30,825.15

Show all line items

Columns are period end dates

Stockrow Weekly